Active Not RecruitingNot applicableNCT06383988

A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources

Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.

Checked against the public recordLast updated Aug 26, 2026 · Source: ClinicalTrials.gov

StatusActive Not Recruiting
PhaseNot applicable
U.S. locations25
SponsorWake Forest University Health Sciences
01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
Wake Forest University Health Sciences
Interventions being studied
Other: Support for Caregiver - Generic List; Other: Support for Caregiver - Personalized List; Other: Internet-Based Intervention - CONNECT; Behavioral: Patient Navigation
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Patient Inclusion Criteria: * Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads * Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer * Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining * Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours * Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate Caregiver Inclusion Criteria: * Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads * Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate * Must have access to the internet at home or be willing to use CONNECT in the clinic * Must have access to telephone to complete sessions with the central caregiver navigator Patient Exclusion Criteria: * Patients who have completed treatment for their lung cancer at the time of study enrollment * Enrolled in hospice care * Unable to read and English and not willing to have someone read surveys for them Caregiver Exclusion Criteria: * Self-report currently receiving cancer treatment * Unable to read and communicate in English, as the CONNECT intervention is currently only available in English

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Kaiser Permanente-FranklinDenver, Colorado
  • Kaiser Permanente - Rock CreekLafayette, Colorado
  • Kaiser Permanente - Lone TreeLone Tree, Colorado
  • Beebe South Coastal Health CampusMillville, Delaware
  • Beebe Health CampusRehoboth Beach, Delaware
  • Augusta University Medical CenterAugusta, Georgia
  • Hawaii Cancer Care Inc - Waterfront PlazaHonolulu, Hawaii
  • Hawaii Cancer Care - Westridge‘Aiea, Hawaii
  • Lake Regional HospitalOsage Beach, Missouri
  • CoxHealth South HospitalSpringfield, Missouri
  • Montefiore Medical Center-Einstein CampusThe Bronx, New York
  • Wake Forest NCORP Research BaseWinston-Salem, North Carolina

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 26, 2026. Always confirm current availability with the study team.

View original record ↗